248 related articles for article (PubMed ID: 20507234)
1. Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Izsvák Z; Ivics Z; Bowers WJ
Hum Gene Ther; 2010 Nov; 21(11):1603-13. PubMed ID: 20507234
[TBL] [Abstract][Full Text] [Related]
2. Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Federoff HJ; Bowers WJ
Gene Ther; 2010 Mar; 17(3):424-31. PubMed ID: 19865178
[TBL] [Abstract][Full Text] [Related]
3. Virion-associated cofactor high-mobility group DNA-binding protein-1 facilitates transposition from the herpes simplex virus/Sleeping Beauty amplicon vector platform.
de Silva S; Lotta LT; Burris CA; Bowers WJ
Hum Gene Ther; 2010 Nov; 21(11):1615-22. PubMed ID: 20568967
[TBL] [Abstract][Full Text] [Related]
4. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
5. Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector.
Bowers WJ; Mastrangelo MA; Howard DF; Southerland HA; Maguire-Zeiss KA; Federoff HJ
Mol Ther; 2006 Mar; 13(3):580-8. PubMed ID: 16412694
[TBL] [Abstract][Full Text] [Related]
6. Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.
Zhang W; Muck-Hausl M; Wang J; Sun C; Gebbing M; Miskey C; Ivics Z; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e75344. PubMed ID: 24124483
[TBL] [Abstract][Full Text] [Related]
7. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
[TBL] [Abstract][Full Text] [Related]
8. Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
[TBL] [Abstract][Full Text] [Related]
9. Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.
Izsvák Z; Hackett PB; Cooper LJ; Ivics Z
Bioessays; 2010 Sep; 32(9):756-67. PubMed ID: 20652893
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
[TBL] [Abstract][Full Text] [Related]
11. Site-directed transposon integration in human cells.
Yant SR; Huang Y; Akache B; Kay MA
Nucleic Acids Res; 2007; 35(7):e50. PubMed ID: 17344320
[TBL] [Abstract][Full Text] [Related]
12. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
[TBL] [Abstract][Full Text] [Related]
13. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
14. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
[TBL] [Abstract][Full Text] [Related]
15. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
Zayed H; Izsvák Z; Walisko O; Ivics Z
Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
[TBL] [Abstract][Full Text] [Related]
16. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene.
Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ
Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635
[TBL] [Abstract][Full Text] [Related]
17. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Huang X; Wilber AC; Bao L; Tuong D; Tolar J; Orchard PJ; Levine BL; June CH; McIvor RS; Blazar BR; Zhou X
Blood; 2006 Jan; 107(2):483-91. PubMed ID: 16189271
[TBL] [Abstract][Full Text] [Related]
18. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
19. Detection of Sleeping Beauty transposition in the genome of host cells by non-radioactive Southern blot analysis.
Aravalli RN; Park CW; Steer CJ
Biochem Biophys Res Commun; 2016 Aug; 477(3):317-21. PubMed ID: 27329815
[TBL] [Abstract][Full Text] [Related]
20. Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type composition.
Peterson EB; Mastrangelo MA; Federoff HJ; Bowers WJ
Mol Ther; 2007 Oct; 15(10):1848-55. PubMed ID: 17653102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
